REVB FY 2021 Earnings — Revelation Biosciences, Inc. Revenue & Financial Results | Market Cap Arena

REVBRevelation Biosciences, Inc.

$2M

FY 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$69,166

Operating Income

-$12M

Net Income

-$12M

EPS (Diluted)

$-20400.00

Cash Flow

Operating Cash Flow

-$11M

Free Cash Flow

-$11M

Stock-Based Comp.

$470,878

Balance Sheet

Total Assets

$2M

Total Liabilities

$2M

Stockholders' Equity

-$99,470

Cash & Equivalents

$1M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$69,166	$0	—
Operating Income	-$12M	-$4M	-214.8%
Net Income	-$12M	-$2M	-635.2%